Meg Crofton - 29 Apr 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: Director
Issuer ticker: HCA
Reported as of: 29 Apr 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 May 2024, 18:18:26 UTC
Prior SEC filing: 20 Nov 2023
Next SEC filing: 25 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Meg Crofton filed Form 4 for HCA Healthcare, Inc. (HCA) on 01 May 2024.

Key facts

This page summarizes Meg Crofton's Form 4 filing for HCA Healthcare, Inc. (HCA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 May 2024, 18:18.

Change

Previous filing in this sequence was filed on 20 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Award

Transaction value: $0
Shares: +610
Change %: +11%
Price: $0.000000
Shares after: 6,331
Date: 29 Apr 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.